Impact News +++ All You Need to Know About Stoke Therapeutics (STOK) Rating Upgrade to Buy (Zacks) +++ STOKE THERAPEUTICS Aktie -4,10%

Gewinn & Umsatz News zur CHARLES RIVER Aktie

>CHARLES RIVER Aktienkurs

142.05 EUR -8.3% (Tradegate)

Ask: 143.25 EUR / 150 Stück

Bid: 142.25 EUR / 150 Stück

Tagesumsatz: 38 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

Aktie über LYNX handeln

Intraday

1 Jahr

>CHARLES RIVER Performance

1 Woche: -9,8%

1 Monat: +0,6%

3 Monate: +5,2%

6 Monate: +42,5%

1 Jahr: -8,9%

laufendes Jahr: -14,1%

>CHARLES RIVER Aktie

Name:

CHARLES RIVER LAB.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1598641074 / 939391

Symbol/ Ticker:

RV6 (Frankfurt) / CRL (NYSE)

Kürzel:

FRA:RV6, ETR:RV6, RV6:GR, NYSE:CRL

Index:

S&P500

Webseite:

http://www.criver.com

Profil:

Charles River Laboratories International, Inc. is ..
>Volltext..

Marktkapitalisierung:

7660.7 Mio. EUR

Unternehmenswert:

9917.39 Mio. EUR

Umsatz:

3506.07 Mio. EUR

EBITDA:

790.04 Mio. EUR

Nettogewinn:

-60.25 Mio. EUR

Gewinn je Aktie:

-1.14 EUR

Schulden:

2427.22 Mio. EUR

Liquide Mittel:

159.46 Mio. EUR

Operativer Cashflow:

685.31 Mio. EUR

Bargeldquote:

0.17

Umsatzwachstum:

-10.17%

Gewinnwachstum:

-114.39%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

CHARLES RIVER

Letzte Datenerhebung:

05.11.25

>Kennzahlen

Aktien/ Unternehmen:

Aktien: 49.21 Mio. St.

Frei handelbar: 98.88%

Leerverk. Aktien: 4.24%

Rückkaufquote: 5.22%

Mitarbeiter: 20100

Umsatz/Mitarb.: 0.18 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 4.64%

Bewertung:

KGV: -

KGV lG: 17.53

KUV: 2.12

KBV: 2.68

PEG-Ratio: -

EV/EBITDA: 12.55

Rentabilität:

Bruttomarge: 29.96%

Gewinnmarge: -1.72%

Operative Marge: 11.86%

Managementeffizenz:

Gesamtkaprendite: -0.89%

Eigenkaprendite: -1.96%

>Peer Group

Es sind 597 Aktien bekannt.

>CHARLES RIVER Chart & Kurs - NYSE

>CHARLES RIVER Gewinn & Umsatz News

05.11.25 - 14:49	Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) reported a profit for third quarter that Decreased from last year but beat the Street estimates.The company's bottom line......

05.11.25 - 14:49	Charles River Laboratories Updates FY25 Earnings Outlook (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International, Inc. (CRL), Wednesday an updated financial outlook for fiscal year 2025.The company now anticipates earnings of $4.15 - $4.35 per s......

23.10.25 - 13:24	What to Expect From Charles River Laboratories′ Q3 2025 Earnings Report (Barchart)
	Charles River Laboratories is all set to release its fiscal third-quarter earnings next month, and analysts project a low double-digit profit decline....

27.08.25 - 16:30	Charles River Laboratories Stock: Analyst Estimates & Ratings (Barchart)
	Despite Charles River Laboratories' weak performance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock's prospects....

06.08.25 - 15:18	Charles River Laboratories International Inc. Profit Drops In Q2 (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed earnings for second quarter that Drops, from the same period last yearThe company's earnings came in at $52.32 m......

18.07.25 - 14:18	Heres What to Expect From Charles River Laboratories Next Earnings Report (Barchart)
	Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company's bottom-line figure....

07.05.25 - 15:18	ROUNDUP: Charles River Boosts FY25 Outlook; Stock Up 22% On Strategic Review Announcement (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Wednesday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings, revenue gr......

07.05.25 - 13:48	Charles River Laboratories International Inc. Q1 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) revealed earnings for first quarter that decreased from last year but beat the Street estimates.The company's earnings to......

28.04.25 - 18:30	Earnings Preview: What To Expect From Charles River Laboratories Report (Barchart)
	Charles River Laboratories is scheduled to announce its first-quarter results next week, with analysts anticipating a single-digit earnings dip....

26.02.25 - 10:48	Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Charles River Laboratories has lagged behind the broader market over the past year, with Wall Street analysts maintaining a cautious outlook on its future performance....

19.02.25 - 13:42	Charles River Laboratories International Inc. Q4 Earnings Summary (AFX)
	WASHINGTON (dpa-AFX) - Below are the earnings highlights for Charles River Laboratories International Inc. (CRL):Earnings: -$214.50 million in Q4 vs. $187.08 million in the same period last year. ......

24.01.25 - 13:54	Charles River Laboratories Quarterly Earnings Preview: What You Need to Know (Barchart)
	Charles River Laboratories will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth....

06.11.24 - 13:31	Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Charles River Laboratories International Inc. (CRL) announced earnings for third quarter that decreased from the same period last year but beat the Street estimates.The comp......

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram